Cited by

• Cost-Effectiveness of Low-Dose Computed Tomography Screenings for Lung Cancer in High-Risk Populations: A Markov Model.

  Sheu CC, Wang CC, Hsu JS, Chung WS, Hsu HY, Shi HY. Sheu CC, et al. World J Oncol. 2024 Aug;15(4):550-561. doi: 10.14740/wjon1882. Epub 2024 Jul 5. World J Oncol. 2024. PMID: 38993243 Free PMC article.
• Kremen2 drives the progression of non-small cell lung cancer by preventing SOCS3-mediated degradation of EGFR.

  Sun Y, Gao Y, Dong M, Li J, Li X, He N, Song H, Zhang M, Ji K, Wang J, Gu Y, Wang Y, Du L, Liu Y, Wang Q, Zhai H, Sun D, Liu Q, Xu C. Sun Y, et al. J Exp Clin Cancer Res. 2023 Jun 3;42(1):140. doi: 10.1186/s13046-023-02692-3. J Exp Clin Cancer Res. 2023. PMID: 37270563 Free PMC article.
• Initial development and testing of an exhaled microRNA detection strategy for lung cancer case-control discrimination.

  Shi M, Han W, Loudig O, Shah CD, Dobkin JB, Keller S, Sadoughi A, Zhu C, Siegel RE, Fernandez MK, DeLaRosa L, Patel D, Desai A, Siddiqui T, Gombar S, Suh Y, Wang T, Hosgood HD, Pradhan K, Ye K, Spivack SD. Shi M, et al. Sci Rep. 2023 Apr 24;13(1):6620. doi: 10.1038/s41598-023-33698-8. Sci Rep. 2023. PMID: 37095155 Free PMC article.
• Personalised Lung Cancer Screening (PLuS) study to assess the importance of coexisting chronic conditions to clinical practice and policy: protocol for a multicentre observational study.

  Braithwaite D, Karanth SD, Slatore CG, Zhang D, Bian J, Meza R, Jeon J, Tammemagi M, Schabath M, Wheeler M, Guo Y, Hochhegger B, Kaye FJ, Silvestri GA, Gould MK. Braithwaite D, et al. BMJ Open. 2022 Jun 22;12(6):e064142. doi: 10.1136/bmjopen-2022-064142. BMJ Open. 2022. PMID: 35732383 Free PMC article.
• Chinese Livery Drivers' Perspectives on Adapting a Community Health Worker Intervention to Facilitate Lung Cancer Screening.

  Leng J, Lui F, Gany F. Leng J, et al. J Health Care Poor Underserved. 2022;33(1):332-348. doi: 10.1353/hpu.2022.0024. J Health Care Poor Underserved. 2022. PMID: 35153223 Free PMC article.